BCL2 and breast cancer: Consistently with a previous report indicating that γ-tocotrienol induced a mitochondrial disruption pathway without affecting Bax/Bcl-2 expression in human breast cancer MDA-MB-231 cells [34], the Bax/Bcl2 ratio was not affected by any of the treatments.